Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.470
+0.020 (4.44%)
At close: Jan 3, 2025, 4:00 PM
0.460
-0.010 (-2.15%)
After-hours: Jan 3, 2025, 7:06 PM EST
RLMD's stock price has decreased by -89.24% in the past year and price targets may not have had time to catch up.
Relmada Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$4.25
Upside
+804.06%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Buy → Hold Downgrades $23 → $1 | Buy → Hold | Downgrades | $23 → $1 | +112.72% | Dec 5, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $10 → $1 | Buy → Hold | Downgrades | $10 → $1 | +112.72% | Dec 4, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $3.5 → $13 | Hold → Strong Buy | Upgrades | $3.5 → $13 | +2,665.37% | Sep 17, 2024 |
Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $3 → $2 | Hold → Strong Sell | Downgrades | $3 → $2 | +325.44% | Jun 5, 2024 |
Mizuho | Mizuho | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +5,430.74% | Jun 15, 2023 |
SVB Leerink | SVB Leerink | Buy Maintains $42 → $10 | Buy | Maintains | $42 → $10 | +2,027.21% | Jan 23, 2023 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $8 | Strong Buy → Hold | Downgrades | $8 | +1,601.77% | Oct 14, 2022 |
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2022 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 13, 2022 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $49 → $81 | Strong Buy | Maintains | $49 → $81 | +17,130.38% | Sep 23, 2022 |
Guggenheim | Guggenheim | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +12,663.24% | Sep 6, 2022 |
Oppenheimer | Oppenheimer | Buy Maintains $75 → $64 | Buy | Maintains | $75 → $64 | +13,514.12% | May 9, 2022 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $69 → $53 | Strong Buy | Maintains | $69 → $53 | +11,174.20% | Mar 24, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +8,834.27% | Dec 20, 2021 |
Mizuho | Mizuho | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +10,536.03% | Nov 18, 2021 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $69 → $40 | Strong Buy → Hold | Downgrades | $69 → $40 | +8,408.83% | Oct 28, 2020 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.